Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Deal Watch: AbbVie Bets On Turnstone’s Cancer Immunotherapy Technology

Executive Summary

AbbVie takes options on three oncolytic virus immunotherapies under development at Turnstone. Amgen and CytomX swap IP in cancer immunotherapy collaboration, while Nicox and pSivida will team to fight glaucoma and other eye diseases.

Advertisement

Related Content

Keeping Track: Flexion's Non-Opioid Knee Pain Drug Gets OK, Botox Gets Another Approval
Cancer-Focused Medivir Licenses AMR Centre Promising Superbug Assets
Siamab, BI Team To ‘Attack’ Potential Of Carbohydrate Antibodies In Cancer
Deal Watch: Are Ultragenyx, REGENXBIO In A Bidding War For Dimension?
Deal Watch: Seattle Genetics Adds To Antibody-Drug Conjugate Portfolio

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

SC099640

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel